republic-os/legislation/us/states/va/2024/hb-516.md

type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags

type	title	description	jurisdiction	legislature	session	identifier	citation	classification	subjects	status	primary_sponsors	version_count	action_count	vote_count	first_action	last_action	source	source_identifier	source_url	source_hash	vintage	source_snapshot	retrieved_at	confidence	tags
Bill	Prescription drugs; labels provided for blind and disabled users.	Prescription drugs; labels; blind and disabledusers. Requires pharmacies to notify any person receiving a prescription drug that an accessible prescription label is availableupon request at no cost and to provide to individuals who are blind,visually impaired, or otherwise print disabled accessible prescriptionlabels that meet specified accessibility requirements. The bill requiresthe Board of Pharmacy to promulgate regulations implementing theprovisions of the bill no later than April 1, 2025.	us/states/va	Virginia General Assembly	2024	HB 516	Virginia HB 516 (2024)	bill		enacted	Patrick A. Hope	4	35	7	2024-01-08	2024-04-08	openstates	ocd-bill/d7afd175-65f7-4269-a4cd-cbff34d66056	https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+HB516	343401ed49e5b02fdbb5bc42c2570bf1bd21dd2ea8a60eabf25a86ad9c46dbd7	2026-07-01	https://data.openstates.org/daily/2026-07-01/public.pgdump	2026-07-06	reported	legislation bill us-va

Virginia HB 516 (2024) — Prescription drugs; labels provided for blind and disabled users.

Prescription drugs; labels; blind and disabledusers. Requires pharmacies to notify any person receiving a prescription drug that an accessible prescription label is availableupon request at no cost and to provide to individuals who are blind,visually impaired, or otherwise print disabled accessible prescriptionlabels that meet specified accessibility requirements. The bill requiresthe Board of Pharmacy to promulgate regulations implementing theprovisions of the bill no later than April 1, 2025.

Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. CHAP0725 (committee substitute) — source
2. Committee substitute printed 24108563D-S1 (committee substitute) — source
3. HB516ER (committee substitute) — source
4. Prefiled and ordered printed; offered 01/10/24 24104715D (committee substitute) — source

Votes

• Reported from Health and Human Services (17-Y 5-N) — 17–5 (pass) · lower
• VOTE: Passage (61-Y 37-N) — 60–37 (pass) · lower
• Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
• VOTE: Adoption (74-Y 26-N) — 73–26 (pass) · lower
• Subcommittee recommends reporting (5-Y 2-N) — 5–2 (pass) · lower
• Passed Senate with substitute (39-Y 0-N) — 39–0 (pass) · upper
• Reported from Education and Health with substitute (13-Y 0-N 2-A) — 13–0 (pass) · upper

Sponsors

• Patrick A. Hope — primary (person)
• Elizabeth B. Bennett-Parker — cosponsor (person)
• Holly M. Seibold — cosponsor (person)
• Irene Shin — cosponsor (person)
• Jackie H. Glass — cosponsor (person)
• Marcia S. "Cia" Price — cosponsor (person)
• Paul E. Krizek — cosponsor (person)

Timeline

The legislative action history — every referral, reading, and vote.

• 2024-01-08 Prefiled and ordered printed; offered 01/10/24 24104715D filing, introduction
• 2024-01-08 Referred to Committee on Health and Human Services referral-committee
• 2024-01-17 Assigned sub: Health referral-committee
• 2024-01-17 Impact statement from DPB (HB516)
• 2024-02-06 Subcommittee recommends reporting (5-Y 2-N)
• 2024-02-08 Reported from Health and Human Services (17-Y 5-N) committee-passage
• 2024-02-11 Read first time reading-1
• 2024-02-12 Read second time and engrossed reading-2
• 2024-02-13 Read third time and passed House (61-Y 37-N) passage, reading-3
• 2024-02-13 VOTE: Passage (61-Y 37-N) passage
• 2024-02-14 Constitutional reading dispensed
• 2024-02-14 Referred to Committee on Education and Health referral-committee
• 2024-02-21 Assigned Education and Health Sub: Health Professions referral-committee
• 2024-02-23 Senate subcommittee amendments and substitutes offered
• 2024-02-29 Senate committee, floor amendments and substitutes offered
• 2024-02-29 Reported from Education and Health with substitute (13-Y 0-N 2-A) committee-passage
• 2024-02-29 Committee substitute printed 24108563D-S1 substitution
• 2024-03-01 Constitutional reading dispensed (40-Y 0-N)
• 2024-03-04 Impact statement from DPB (HB516S1)
• 2024-03-04 Read third time reading-3
• 2024-03-04 Reading of substitute waived
• 2024-03-04 Committee substitute agreed to 24108563D-S1 substitution
• 2024-03-04 Engrossed by Senate - committee substitute HB516S1 substitution
• 2024-03-04 Passed Senate with substitute (39-Y 0-N) passage
• 2024-03-05 Senate substitute agreed to by House 24108563D-S1 (74-Y 26-N) substitution
• 2024-03-05 VOTE: Adoption (74-Y 26-N)
• 2024-03-25 Enrolled enrolled
• 2024-03-25 Bill text as passed House and Senate (HB516ER) passage
• 2024-03-25 Signed by President passage
• 2024-03-26 Signed by Speaker passage
• 2024-03-27 Impact statement from DPB (HB516ER)
• 2024-03-27 Enrolled Bill communicated to Governor on March 27, 2024 enrolled, executive-receipt
• 2024-03-27 Governor's Action Deadline 11:59 p.m., April 8, 2024 executive-receipt
• 2024-04-08 Approved by Governor-Chapter 725 (effective 7/1/24) executive-signature
• 2024-04-08 Acts of Assembly Chapter text (CHAP0725)

Source

OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/d7afd175-65f7-4269-a4cd-cbff34d66056. Confidence: reported (aggregated from official Virginia legislature records).